Search is Powered by Google
Cancer / Oncology News

Australian Disease Research Boosted By National Alliance

Main Category: Cancer / Oncology
Also Included In: Diabetes;  Immune System / Vaccines;  Public Health
Article Date: 23 Aug 2008 - 0:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:not yet rated

Health Professional:not yet rated

Article Opinions: 0 posts

Nine of the nation's leading scientific research institutions have launched a new partnership to boost Australia's research capacity for tackling major health problems including cancer, diabetes, deafness, infertility, autoimmune disease and arthritis.

The Australian Phenomics Network (APN) is providing Australian and International researchers with the latest infrastructure for the study of human disease. The alliance brings together facilities, equipment and expertise to accelerate progress in the provision of biological models for medical research. This facilitates Australia making genuine inroads against all kinds of diseases.

"This is incredibly exciting science - frontier science - and it's great to see Australian researchers leading the way," said Senator Kim Carr, Minister for Innovation, Industry, Science and Research.

APN Chief Scientific Officer Professor Chris Goodnow said: "Together we'll be able to access biological models that have been developed for specific research projects. Combining our technical resources means we can spend more time actually doing the research that will make a real difference in our efforts to combat diseases."

APN Convenor Associate Professor Moira O'Bryan from Monash University said the project is about combining efforts and supporting all Australian researchers. "Australia has a wealth of talent in medical research, spread across a number of institutions. Each organisation has its own strengths in different areas," she says. "The APN will allow our resources to be combined and greatly enhance Australia's research capacity."

The APN is also working with the Atlas of Living Australia project to develop a framework for building web resources that capture, annotate and disseminate research data and will enable research outcomes to be translated to clinical outcomes more rapidly.

The APN is funded by the Australian Government's National Collaborative Research Infrastructure Strategy (NCRIS), contributions from state governments, and the National Health and Medical Research Council (NHMRC).

The network combines the resources of the Australian National University, Monash University, the Walter and Eliza Hall Institute for Medical Research, the University of Melbourne, Queensland Institute of Medical Research, the Institute of Medical and Veterinary Science, the Centenary Institute of Cancer Medicine and Cell Biology, Menzies Research Institute and the Animal Resource Centre.

The APN's expertise is complemented by national and international partnerships with the Garvan Institute, the Institute of Molecular Bioscience, the National Institutes of Health (USA), the Wellcome Trust (UK) and the University of Manitoba (Canada).

----------------------------
Article adapted by Medical News Today from original press release.
----------------------------

Source: Simon Couper
Research Australia




Customized Homepage Weekly Newsletters Daily News Alerts
Home About Us News Licensing Free Website Feeds Free Tools & Content Links Tell a Friend Accessibility Help / FAQ Article Submission Contact Us
Urology
ADHD Autism Diabetes

add medical news today to your facebook

medical news gadget

Add to Google


developers
website gadget code
website news code
medical news rss feed links


customize your homepage


These are the most read articles from this news category for the last 6 months:
Top Article Star
Shocking Pictures To Appear On Cigarette Packets In UK On 1st October
27 Sep 2008
The UK's ten million Smokers may see pictures of rotting teeth, throat cancer, and indications of male impotence (erectile dysfunction) on cigarette packets they buy at the beginning of October...


Monitoring and Adherence in CML image Monitoring and Adherence in CML

Imatinib, or Gleevec, is a targeted anti-cancer drug that can keep chronic myelogenous leukemia (CML) in check for most patients for many years. It is important for patients to take imatinib as prescribed by their doctor to fight the disease and to guard against resistance...

Treating HER2+ Breast Cancer image Treating HER2+ Breast Cancer

There are at least four different kinds of breast cancer and each is treated differently. For HER2+ breast cancer, a chemotherapy drug is typically the best option. Here's an overview of the drugs used to treat breast cancer...

View more videos...